Orosomucoid 2 upregulation mediates liver injury‐induced colorectal cancer liver metastasis by promoting EMT and cell migration
Cancer Science · 2025
DOI: 10.1111/cas.16131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Xundong Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Biotherapy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cell Movement, Epithelial-Mesenchymal Transition, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangxi Science And Technology Base and Talent Special Projects, CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
The relationship between drug‐induced liver injury and liver metastasis of colorectal cancer and the underlying mechanisms are not well understood. In this study, we used carbon tetrachloride to construct a classic mouse liver injury model and injected CT26 colorectal cancer cells into the mouse spleen to simulate the natural route of colorectal cancer liver metastasis. Liver injury significantly increased the number of colorectal cancer liver metastases. Transcriptome sequencing and data‐independent acquisition protein quantification identified proteins that were significantly differentially expressed in injured livers, and orosomucoid (ORM) 2 was identified as a target protein for tumor liver metastasis. In vitro experiments showed that exogenous ORM2 protein increased the expression of EMT markers such as Twist, Zeb1, Vim, Snail1 and Snail2 and chemokine ligands to promote CT26 cell migration. In addition, liver‐specific overexpression of the ORM2 protein in the mouse model significantly promoted tumor cell liver metastasis without inducing liver injury. Our results indicate that drug‐induced liver injury can promote colorectal cancer liver metastasis and that ORM2 can promote cell migration by inducing EMT in tumor cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Biotherapy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
- Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Medical Laboratory Center, Chifeng Municipal Hospital/Chifeng Clinical College, Inner Mongolia Medical University, Chifeng, China.
- National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, China.
ORCID-Profile: Xundong Wei, Jie Ma
Förderung
- Guangxi Science And Technology Base and Talent Special Projects
- CAMS Innovation Fund for Medical Sciences
- National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Wei, X., Wang, L., Yang, B., Ma, Y., Yuan, W., & Ma, J. (2025). Orosomucoid 2 upregulation mediates liver injury‐induced colorectal cancer liver metastasis by promoting EMT and cell migration. Cancer Science. https://doi.org/10.1111/cas.16131
Vancouver
Wei X, Wang L, Yang B, Ma Y, Yuan W, Ma J. Orosomucoid 2 upregulation mediates liver injury‐induced colorectal cancer liver metastasis by promoting EMT and cell migration. Cancer Science. 2025. doi:10.1111/cas.16131
BibTeX
@article{Wei2025,
author = {Wei, Xundong and Wang, Lei and Yang, Bing and Ma, Yuanyuan and Yuan, Wei and Ma, Jie},
title = {Orosomucoid 2 upregulation mediates liver injury‐induced colorectal cancer liver metastasis by promoting EMT and cell migration},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16131}
}
EUVIMED